Cliff Asness's NAGE Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 472,056 shares of Niagen Bioscience, Inc. (NAGE) worth $1.51 M, representing 0.00% of the portfolio. First purchased in 2019-Q3, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in NAGE, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 425,381 shares. Largest reduction occurred in Q2 2026, reducing 559,279 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Niagen Bioscience (NAGE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Niagen Bioscience (NAGE) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -559,279 | Reduce 54.23% | 472,056 | $3.19 |
| Q1 2026 | +425,381 | Add 70.20% | 1.03 M | $4.41 |
| Q4 2025 | +18,957 | Add 3.23% | 605,954 | $6.36 |
| Q3 2025 | +95,386 | Add 19.40% | 586,997 | $9.33 |
| Q2 2025 | +139,475 | Add 39.61% | 491,611 | $14.41 |
| Q1 2025 | +329,425 | Add 1450.51% | 352,136 | $6.90 |
| Q4 2024 | +3,075 | Add 15.66% | 22,711 | $5.31 |
| Q3 2024 | +19,636 | New Buy | 19,636 | $3.65 |
| Q4 2022 | -76,571 | Sold Out | 0 | $0.00 |
| Q3 2022 | -156,232 | Reduce 67.11% | 76,571 | $1.23 |
| Q2 2022 | -180,986 | Reduce 43.74% | 232,803 | $1.67 |
| Q1 2022 | +181,358 | Add 78.03% | 413,789 | $2.46 |
| Q4 2021 | +60,590 | Add 35.26% | 232,431 | $3.74 |
| Q3 2021 | +55,854 | Add 48.16% | 171,841 | $6.27 |
| Q2 2021 | +38,650 | Add 49.98% | 115,987 | $9.86 |
| Q1 2021 | -81,559 | Reduce 51.33% | 77,337 | $9.34 |
| Q4 2020 | +17,695 | Add 12.53% | 158,896 | $4.80 |
| Q3 2020 | +141,201 | New Buy | 141,201 | $4.01 |
| Q4 2019 | -23,024 | Sold Out | 0 | $0.00 |
| Q3 2019 | +23,024 | New Buy | 23,024 | $3.95 |
Cliff Asness's Niagen Bioscience Investment FAQs
Cliff Asness first purchased Niagen Bioscience, Inc. (NAGE) in Q3 2019, acquiring 23,024 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Niagen Bioscience, Inc. (NAGE) for 20 quarters since Q3 2019.
Cliff Asness's largest addition to Niagen Bioscience, Inc. (NAGE) was in Q1 2026, adding 1,031,335 shares worth $4.55 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 472,056 shares of Niagen Bioscience, Inc. (NAGE), valued at approximately $1.51 M.
As of the Q2 2026 filing, Niagen Bioscience, Inc. (NAGE) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Niagen Bioscience, Inc. (NAGE) was 1,031,335 shares, as reported at the end of Q1 2026.